Jeff Goater - 10 Jun 2021 Form 4 Insider Report for Surface Oncology, Inc.

Role
Director
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Jun 2021
Net transactions value
-$900,545
Form type
4
Filing time
11 Jun 2021, 20:30:12 UTC
Previous filing
12 May 2021
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SURF Common Stock Options Exercise $828,000 +200,000 +76% $4.14 462,000 10 Jun 2021 Direct
transaction SURF Common Stock Options Exercise $143,770 +34,727 +7.5% $4.14 496,727 10 Jun 2021 Direct
transaction SURF Common Stock Sale $1,798,619 -234,727 -47% $7.66* 262,000 10 Jun 2021 Direct F1
transaction SURF Common Stock Options Exercise $42,530 +10,273 +3.9% $4.14 272,273 11 Jun 2021 Direct
transaction SURF Common Stock Sale $116,226 -15,273 -5.6% $7.61* 257,000 11 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Options Exercise $0 -200,000 -66% $0.000000 104,104 10 Jun 2021 Common Stock 200,000 $4.14 Direct F3
transaction SURF Stock Option (Right to Buy) Options Exercise $0 -34,727 -77% $0.000000 10,325 10 Jun 2021 Common Stock 34,727 $4.14 Direct F4
transaction SURF Stock Option (Right to Buy) Options Exercise $0 -10,273 -9.9% $0.000000 93,831 11 Jun 2021 Common Stock 10,273 $4.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $7.56 to $7.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F2 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $7.58 to $7.64. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
F3 The stock option is fully vested and exercisable as of the date hereof.
F4 The stock option vests and becomes exercisable in 48 equal monthly installments after the closing of the Issuer's initial public offering.